Do you want to read an article? Please log in or register.
Automated quantification of macular fluid in retinal diseases and their response to anti-VEGF therapy
Macular DiseasesRetinal Diseases
COMMENTED
Related content
Macular Diseases
Application of Automated Quantification of Fluid Volumes to Anti-VEGF Therapy of Neovascular Age-Related Macular Degeneration
Ophthalmology.
Schmidt-Erfurth U, Vogl WD, Jampol LM, Bogunović H
doi: 10.1016/j.ophtha.2020.03.010.
Retinal Diseases
Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion
JAMA Ophthalmol.
Babiuch AS, Han M, Conti FF, Wai K, Silva FQ, Singh RP
doi: 10.1001/jamaophthalmol.
Macular DiseasesRetinal Diseases
Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy: an optical coherence tomography study
Clin Ophthalmol.
Kulikov AN, Sosnovskii SV, Berezin RD, Maltsev DS, Oskanov DH, Gribanov NA
doi: 10.2147/OPTH.S146019.
RECOMMENDED
Macular DiseasesRetinal Diseases
Retinal venous pressure is decreased after anti-VEGF therapy in patients with retinal vein occlusion-related macular edema
★ 1
Recommended by
Prof. Dr emer. Josef Flammer, Faculty Member
Graefes Arch Clin Exp Ophthalmol
Kida T, Flammer J, Konieczka K, Ikeda T
doi: 10.1007/s00417-020-05068-x
Macular DiseasesRetinal Diseases
Differential Response to Anti-VEGF Regimens in Age-Related Macular Degeneration Patients with Early Persistent Retinal Fluid
Ophthalmology.
Jaffe GJ, Kaiser PK, Thompson D, Gibson A, Saroj N, Vitti R, Berliner AJ, Heier JS
doi: 10.1016/j.ophtha.2016.05.016.
Further Publications
AI-based monitoring of retinal fluid in disease activity and under therapy
Prog Retin Eye Res
Schmidt-Erfurth U, Reiter GS, Riedl S, Seeböck P, Vogl WD, Blodi BA, Domalpally A, Fawzi A, Jia Y, Sarraf D, Bogunovic H
doi: 10.1016/j.preteyeres.2021.100972
Retinal Diseases
Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy - a systematic approach to identify and characterize data sources
BMC Ophthalmol.
Daien V, Eldem BM, Talks JS, Korobelnik JF, Mitchell P, Finger RP, Sakamoto T, Wong TY, Evuarherhe O, Carter G, Carrasco J
doi: 10.1186/s12886-019-1208-9.
Macular Diseases
Association of Genetic Variants With Response to Anti-Vascular Endothelial Growth Factor Therapy in Age-Related Macular Degeneration
JAMA Ophthalmol.
Lorés-Motta L, Riaz M, Grunin M, Corominas J, van Asten F, Pauper M, Leenders M, Richardson AJ, Muether P, Cree AJ, Griffiths HL, Pham C, Belanger MC, Meester-Smoor MA, Ali M, Heid IM, Fritsche LG, Chakravarthy U, Gale R, McKibbin M, Inglehearn CF, Schlingemann RO, Omar A, Chen J, Koenekoop RK, Fauser S, Guymer RH, Hoyng CB, de Jong EK, Lotery AJ, Mitchell P, den Hollander AI, Baird PN, Chowers I
doi: 10.1001/jamaophthalmol.
Macular DiseasesRetinal DiseasesFurther Publications
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial
JAMA Ophthalmol
Aref AA, Scott IU, VanVeldhuisen PC, King J, Ip MS, Blodi BA, Oden NL, Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Investigator Group.
doi: 10.1001/jamaophthalmol.2021.4395